Driving partner success with reliable, expert-driven CDMO services
At Bora Pharmaceuticals, it is our shared responsibility to execute every drug program reliably on time, consistently in full.
A global pharmaceutical manufacturing partner
- From sites in North America and Asia, Bora delivers reliable, high-quality drug products to 100+ markets around the globe
Bora Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in formulation development, clinical and commercial cGMP manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologic, and sterile injectable pharmaceutical products.
From our nine cGMP facilities across three countries, Bora Pharmaceuticals delivers drug products with unparalleled quality to more than 100 markets around the world. Bora’s teams, technologies, and facilities work seamlessly together with a shared commitment to supporting partners, minimizing risk, and helping ensure therapies reach patients worldwide.
State-of-the-art manufacturing sites
inspected and approved by global regulatory bodies
Manufacturing space
across our facilities in North America and Asia
Years of experience
in development, manufacturing, and packaging of Rx and OTC medications
Invested
in world-class facilities, equipment, and personnel
Comprehensive small molecule development and manufacturing capabilities
- Leverage Bora’s premium contract manufacturing and packaging services for oral solid doses (OSD), semi-solids, liquids, nasal sprays, and ophthalmic drugs, backed by expert teams and state-of-the-art technologies. With integrated formulation development services, scalable manufacturing capabilities, and responsive partner support, Bora Pharmaceuticals helps partners minimize risk and accelerate timelines.
Bora’s global manufacturing footprint
- Our worldwide presence and deep regulatory expertise enable partners to meet country-specific commercial and regulatory requirements, ensuring therapies reach patients worldwide in the most efficient way possible
Bora currently owns and operates nine cGMP manufacturing facilities – in Taiwan, Canada, and the United States – built to the highest international standards for pharmaceutical development, manufacturing, packaging, labeling, and analytical testing.
We manufacture and supply finished drug products to countries in North, Central, and South America, Europe, Russia, the Middle East, and Asia, as well as Australia and New Zealand.
Manufacturing sites approved by global regulatory authorities including USFDA, MHRA, Health Canada, ANVISA, Japan FDA, Russian Ministry, Turkish MoH, Korean FDA, PIC/S, GMP, TFDA, Jordan FDA, and GCC (Gulf Cooperation Council).
